(Q47342870)

English

The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation

scientific article published on 20 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

Daniela Ferrante

7

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

Armando A. Genazzani

8

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

author name string

P Stratta

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

M Quaglia

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

T Cena

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

R Antoniotti

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

R Fenoglio

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

A Menegotto

6

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

S Terrazzino

9

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

C Magnani

10

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

publication date

20 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

68

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

671-680

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

Tacrolimus: a further update of its use in the management of organ transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Pharmacogenetics of calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Dexamethasone modulation of multidrug transporters in normal tissues.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Guidelines for the treatment and management of new-onset diabetes after transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

High initial blood levels of tacrolimus in overweight renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Genetic contribution to variable human CYP3A-mediated metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Pharmacogenetics in solid organ transplantation: current status and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Dosing tacrolimus based on CYP3A5 genotype: will it improve clinical outcome?

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Pharmacogenomics: unlocking the human genome for better drug therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Update on the clinical pharmacogenomics of organ transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Individualizing calcineurin inhibitor therapy in renal transplantation--current limitations and perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1150-0

21 January 2018

Calcineurin inhibitor nephrotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in tacrolimus trough levels after steroid withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of tacrolimus: a moving matter.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors responsible for inter-individual variations in dosage/concentration of tacrolimus in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A highly sensitive method to assay FK-506 levels in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimization of initial tacrolimus dose using pharmacogenetic testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements

1 reference

https://pubmed.ncbi.nlm.nih.gov/22101623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-011-1150-0

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/22101623

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47342870&oldid=2208554036"